Challenges in secondary stroke prevention: prevalence of multiple metabolic risk factors, including abnormal glycaemia, in ischaemic stroke and transient ischaemic attack

被引:7
|
作者
Scott, D. P. [2 ]
Greenfield, J. R. [1 ,2 ,3 ]
Bramah, V. [4 ]
Alford, J. [3 ]
Bennett, C. [3 ,4 ]
Markus, R. [2 ,5 ]
Campbell, L. V. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Dept Endocrinol, Sydney, NSW 2010, Australia
[2] Univ New S Wales, Sydney, NSW, Australia
[3] St Vincents Hosp, Ctr Diabet, Sydney, NSW 2010, Australia
[4] St Vincents Hosp, Acute Stroke Unit, Sydney, NSW 2010, Australia
[5] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia
关键词
ischaemic stroke; transient ischaemic attack; pre-diabetes; diabetes; metabolic syndrome; CORONARY-HEART-DISEASE; POSTSTROKE HYPERGLYCEMIA; ADMISSION HYPERGLYCEMIA; DIABETES-MELLITUS; GLUCOSE; INTERVENTION; ASSOCIATION; GUIDELINES; MANAGEMENT; MORTALITY;
D O I
10.1111/j.1445-5994.2009.01941.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Secondary prevention of ischaemic stroke (IS) and transient ischaemic attack (TIA) mandates identification and treatment of multiple metabolic risk factors. The aim was to determine the prevalence of abnormal glycaemia, hypertension and dyslipidaemia in patients presenting to an Acute Stroke Unit of a tertiary referral teaching hospital with IS or TIA. Methods: We reviewed the clinical characteristics of consecutive patients presenting with symptoms of acute stroke or TIA between 1 February 2006 and 30 June 2007 to determine the prevalence of diabetes, impaired fasting glucose (IFG), post-stroke dysglycaemia (PSD), hypertension and dyslipidaemia. Results: Mean age +/- SD of the 224 patients (84 female) was 71 +/- 15 years. Seventy per cent (n = 157) of patients presented with IS and 30% (n = 67) with TIA. Of the cohort, 15% (n = 33) had previously diagnosed diabetes, 10% (n = 22) were diagnosed with diabetes during admission and 19% (n = 42) had IFG diagnosed during admission. A further 4% (n = 9) were classified as having PSD. Sixty-two per cent (n = 139) of patients had previously diagnosed hypertension; another 7% (n = 15) were diagnosed during admission. Eighty-eight per cent (n = 197) of patients had dyslipidaemia. Thirty per cent had all three risk factors concurrently. Conclusion: Abnormal glycaemia was present in almost half the patients presenting with IS/TIA, with the majority of cases undiagnosed. One-third of patients had abnormal glycaemia, hypertension and dyslipidaemia concurrently. Patients presenting with stroke should be routinely screened for abnormal glycaemia in concert with other vascular risk factors.
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [1] Prevention of stroke and transient ischaemic attack
    Jackson, PR
    Wallis, EJ
    Ramsay, LE
    [J]. LANCET, 2001, 358 (9283): : 762 - 762
  • [2] Secondary prevention medication persistence and prognosis of acute ischaemic stroke or transient ischaemic attack
    Zhang, Lei
    Shi, Junfeng
    Pan, Yuesong
    Li, Zixiao
    Yan, Hongyi
    Liu, Chelsea
    Lv, Wei
    Meng, Xia
    Wang, Yongjun
    [J]. STROKE AND VASCULAR NEUROLOGY, 2021, 6 (03) : 376 - 383
  • [3] Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention
    Markus, Hugh S.
    van der Worp, H. Bart
    Rothwell, Peter M.
    [J]. LANCET NEUROLOGY, 2013, 12 (10): : 989 - 998
  • [4] Atorvastatin in prevention of stroke and transient ischaemic attack
    Arnarenco, Pierre
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (16) : 2789 - 2797
  • [5] Prevalence and risk factors of symptomatic carotid stenosis in patients with recent transient ischaemic attack or ischaemic stroke in the Netherlands
    den Brok, Melina G. H. E.
    Kuhrij, Laurien S.
    Roozenbeek, Bob
    van der Lugt, Aad
    Hilkens, Pieter H. E.
    Dippel, Diederik W. J.
    Nederkoorn, Paul J.
    [J]. EUROPEAN STROKE JOURNAL, 2020, 5 (03) : 271 - 277
  • [6] ABC of arterial and venous disease - Secondary prevention of transient ischaemic attack and stroke
    Lees, KR
    Bath, PMW
    Naylor, AR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7240): : 991 - 994
  • [7] Statins after transient ischaemic attack and ischaemic stroke
    Hankey, Graeme J.
    [J]. LANCET NEUROLOGY, 2006, 5 (10): : 810 - 812
  • [8] Stroke risk prediction after transient ischaemic attack
    Kim, Anthony S.
    [J]. LANCET NEUROLOGY, 2016, 15 (12): : 1199 - 1200
  • [9] Dementia risk after transient ischaemic attack and stroke
    Dichgans, Martin
    [J]. LANCET NEUROLOGY, 2019, 18 (03): : 223 - 225
  • [10] Stroke Care 1 Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke
    Rothwell, Peter M.
    Algra, Ale
    Amarenco, Pierre
    [J]. LANCET, 2011, 377 (9778): : 1681 - 1692